Cellular responses to Cisplatin-induced DNA damage. - Wikidata - awgldk - TriplyDB

Cellular responses to Cisplatin-induced DNA damage.

Cellular responses to Cisplatin-induced DNA damage.

http://www.wikidata.org/entity/Q34089685

about

C-Jun N-terminal kinase signalling pathway in response to cisplatin A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stress Genetic instability in budding and fission yeast-sources and mechanisms Sky1 regulates the expression of sulfur metabolism genes in response to cisplatin Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells.Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells.Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy.Cisplatin in cancer therapy: molecular mechanisms of action Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.THAP5 is a DNA-binding transcriptional repressor that is regulated in melanoma cells during DNA damage-induced cell death Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.Effects of targeted phosphorylation site mutations in the DNA-PKcs phosphorylation domain on low and high LET radiation sensitivity.Elemental bioimaging of Cisplatin in Caenorhabditis elegans by LA-ICP-MS Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells.The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells.Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro.Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts.JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma Architecture of the human XPC DNA repair and stem cell coactivator complex.Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.Therapeutic interventions to disrupt the protein synthetic machinery in melanoma DNA damage response in cisplatin-induced nephrotoxicity.Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells.Preclinical Assessment of Low Doses of Cisplatin in the Management of Acute Promyelocytic Leukemia miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer Induction of apoptosis and non-apoptosis in human breast cancer cell line (MCF-7) by cisplatin and caffeine.Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells.

P2860

Q26745463-9EF5D1FE-A8DC-4477-862D-B7F1B6A88FF1 Q27014076-863DB9E7-0A95-4666-B4BD-EBA2DB9DD1D8 Q28264035-7EB5A0C9-EEF6-4F12-8A56-7233A2D3422B Q28389083-51A9ADF6-8B88-48EC-B01B-613170CE3CEB Q28484603-97EAA36F-1531-4728-9162-90A03433B85C Q28546838-A5CDCEDD-5E68-47E5-8E25-DC614291C301 Q28546961-75455A89-DC31-4160-8949-97BB5656ED89 Q28553961-004D758F-4947-4C17-9A90-270742F0A2B5 Q33578581-1C21722B-0A23-4246-BD94-D5EE2DD63092 Q33686970-0572F8E2-2D67-4908-9358-C9064B467AD9 Q33742311-9824318E-8620-4C8E-962A-DAEA5AFA72D0 Q33827802-9AB81C64-96D7-4E64-AF2C-2020080BCF53 Q34098163-A28CC6A9-6561-458E-AE76-2A3FDF39392B Q34540820-F2FF0C0D-E12C-4EF9-A6FA-579CDF879599 Q34555628-F7F23516-8299-46BD-9E0E-9C9AE1C254B8 Q34762678-2ABEAF95-25AC-4F00-8C58-FA3B8F7E04E4 Q35135920-0DBC6CE1-6636-4E01-82AE-F5A5AD0A8387 Q35167659-015346BD-3670-4441-A5B5-E6705F08313F Q35638073-2EC8AC7B-A5EB-4393-B6FF-1EE5BAE46C55 Q35728790-D1A71B70-B433-4B0B-9502-9D56D2D2A106 Q35853383-4DAE41BE-1BA4-46E2-A4E6-547F3A08D850 Q35917703-51F3EBB2-105E-4646-AB19-FF0F95C018F8 Q35925499-252635F4-2B3A-4501-83E0-5D069F13B3A1 Q35944751-8E6D010D-8D6D-4E3B-9A0B-DFBE7AC30DFE Q35953034-A7F9AD30-BC4B-4CC3-8F77-A1BB58F3515B Q36001329-164F2C77-6C84-458C-8A6E-03A7D69D3CC1 Q36041749-84FA167A-BC30-4F72-BF2D-0E4949484CE5 Q36140933-32C301B9-8421-43C8-AC10-CCAEF85328CE Q36235684-C99F0E5B-76B9-4209-8A22-30D584895492 Q36291991-C425268C-1969-4081-9AC3-C2ED99BBFCC2 Q36305476-8404093F-0794-4A72-BEB8-62B5D1EE0FE2 Q36354974-F36E6DA7-C0F8-4336-BBDA-8E3522D7636D Q36405766-420A37C1-E17C-4AAC-A20E-FDF9EDF504DB Q36473355-BB7D340C-AA77-4090-8C76-6E854079DC8B Q36525449-811C215C-68AA-4FDA-AF57-961E7E07FFCE Q36585797-9B76A190-E367-42A1-809F-656343C73948 Q36593474-27D4F2A3-4BD2-4F59-881C-3C96B61F5118 Q36729390-24E76479-BBDF-4334-8F32-7D552F54D745 Q36734272-DD0675BD-FD27-4BE6-8A51-06A9CD50DB53 Q36741804-48B2F9A6-456C-4F07-907D-CB0D2B4346BA

P2860

Cellular responses to Cisplatin-induced DNA damage.

http://www.wikidata.org/entity/Q34089685

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cellular responses to Cisplatin-induced DNA damage.

@ast

Cellular responses to Cisplatin-induced DNA damage.

@en

Cellular responses to Cisplatin-induced DNA damage.

@nl

type

label

Cellular responses to Cisplatin-induced DNA damage.

@ast

Cellular responses to Cisplatin-induced DNA damage.

@en

Cellular responses to Cisplatin-induced DNA damage.

@nl

prefLabel

Cellular responses to Cisplatin-induced DNA damage.

@ast

Cellular responses to Cisplatin-induced DNA damage.

@en

Cellular responses to Cisplatin-induced DNA damage.

@nl

P1433

Q34089685-FFE281E8-0E61-4DC4-9B3A-8388FFD684D6

P1476

Q34089685-BB4DD00B-B0A0-42F5-A051-3DC700CD0AE5

P2093

Q34089685-416B95A8-68B8-405D-B340-E92C94F37B89

Q34089685-BB21CB13-B6FA-4A02-A817-C50051EF9135

P2860

Q34089685-018ED47A-99EF-4C38-9007-990232EF6BDA

Q34089685-01DF2C91-0000-4571-AE47-D6B4E43FCF11

Q34089685-0294FABD-9AB8-488C-A21D-95F30D0E6DDA

Q34089685-02F74705-DB16-455C-87B1-329944B3DE53

Q34089685-03152F47-45C7-4D70-8B4D-8D0512489616

Q34089685-0395D791-4A9C-489B-A2DF-B25576BE1647

Q34089685-03D0881A-0DDE-46F2-ABEB-2C525A0ED080

Q34089685-0455130C-5009-4BC5-811C-800022A35DEE

Q34089685-05BC313C-5466-4492-89E6-4B459C3EC979

Q34089685-0693C522-3B30-4CFE-87D6-91F4F8D434D7

P31

Q34089685-2759E775-6810-4CBE-B50E-71EF8A6A43B0

P356

Q34089685-FE6CFD91-32B7-40F4-BE34-9162BE9B7DA3

P478

Q34089685-0E61C7F1-3548-467E-B845-590B95B0D58C

P577

Q34089685-EAC81CE1-19CA-4B89-BE7D-023A2B25B834

P5875

Q34089685-42DDE9FA-AC60-4AC6-9B46-C85B326A9622

P698

Q34089685-867AEEAE-B70F-47E0-8642-0EFFEE105DB0

P921

Q34089685-CF87A646-2225-4060-BF7F-B7B189B84E33

P932

Q34089685-91A91D3A-1909-465A-B428-0F98B9C2865B

P356

P1433

Journal of Nucleic Acids

P1476

Cellular responses to Cisplatin-induced DNA damage.

@en

P2093

Alakananda Basu

http://www.w3.org/2001/XMLSchema#string

Soumya Krishnamurthy

http://www.w3.org/2001/XMLSchema#string

P2860

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis

Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase

Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage

Reaction of human metallothionein-3 with cisplatin and transplatin

Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor

Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta

Mechanism of transcriptional stalling at cisplatin-damaged DNA

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

P31

scholarly article

P356

10.4061/2010/201367

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46111335

http://www.w3.org/2001/XMLSchema#string

P698

20811617

http://www.w3.org/2001/XMLSchema#string

P921

P932

2929606

http://www.w3.org/2001/XMLSchema#string